MiNK Therapeutics, Inc.
INKT
$8.41
-$0.34-3.89%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 54.88% | 64.69% | 56.40% | 32.94% | 29.75% |
| Total Depreciation and Amortization | 0.56% | 17.01% | -13.10% | 17.72% | 41.42% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -36.19% | -226.80% | -29.42% | -35.24% | 65.02% |
| Change in Net Operating Assets | -101.69% | 29.91% | -105.84% | 75.96% | -51.88% |
| Cash from Operations | 43.09% | 28.85% | 44.82% | 41.78% | 31.48% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 126.67% | 26,292.27% | -84.84% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 126.67% | 7,770.15% | 1,597.28% | -100.00% |
| Foreign Exchange rate Adjustments | -646.51% | -54.24% | -211.48% | 49.49% | -87.85% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 42.24% | 29.31% | 181.89% | 151.65% | 32.97% |
